# Pass 35 Validation — CodeUpdate0306

Status: **PASS (static validation)**

## Pass 35 focused validation

- `validate_pass35_classic_worldgroup_rng_callsite_boundary.py`: **136/136 PASS**
- Python validator syntax compilation: **PASS**
- Generation readiness: **PASS**, 32 object families, 0 failures
- Librarium assertion integrity: **PASS**, 20,826 nodes / 71,026 relationships / 0 missing sources / 0 missing entity targets / 0 duplicate-edge diagnostics
- Actual `WCCMMUD.INI` files in reconstructed repository: **0**

## Retained regression suite

- Pass 15: **60/60 PASS**
- Pass 24: **53/53 PASS**
- Pass 26: **70/70 PASS**
- Pass 27: **68/68 PASS**
- Pass 28: **51/51 PASS**
- Pass 29: **78/78 PASS**
- Pass 30: **56/56 PASS**
- Pass 31: **57/57 PASS**
- Pass 32: **109/109 PASS**
- Pass 33: **93/93 PASS**
- Pass 34: **106/106 PASS**

Historical validators were changed only where necessary to accept the current 0306 assertion-ledger / remaining-system registry pointer; their historical evidence files and historical scorecards remain unchanged.

## Exact Pass 35 boundary

For the retained exact MajorMUD module versions, the native analyzer reports 146 direct `_genrdn` import-thunk calls and 42 direct `_lngrnd` import-thunk calls per WCCMMUD/WBBMMUD module. The evidence artifact retains only 64 explicit `_genrdn` addresses per module while retaining all 42 `_lngrnd` addresses. Pass 35 preserves that distinction and does not reconstruct missing addresses.

No gameplay RNG caller was rewritten. Indirect paths, gameplay semantic attribution, Worldgroup execution-thread CRT-state mapping, gameplay-wide draw ordering, and instruction-equivalent `_genrdn`/`_lngrnd` bounded-remainder execution remain UNKNOWN/fail-closed.

## Build status

A .NET build was **not run** because this environment has no `dotnet`, `csc`, `msbuild`, `mono`, or `mcs` executable. Static source/regression validation passed; this report does not claim a compiled build.

## Parity after Pass 35

**97 PASS / 76 STRONG / 27 UNKNOWN = 200**

- Strict parity: **48.5%**
- Evidence-backed: **86.5%**
